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ABSTRACT
Background and Objectives: The prevalence of diabetes mellitus worldwide was 171 million one and
half decade ago, while the prediction is 366 million patients by 2030 and more than 640 million people by
2040. HbA1c value represents average blood glucose over the past 2-3 months and accounts for both preprandial and post-prandial blood glucose levels. A link between HbA1c and diabetic complications has been
confirmed. In general, patients with controlled diabetes mellitus should have at least biannual testing,
while patients with uncontrolled diabetes mellitus or unmet glycemic targets should be tested every three
months. The objective was to see compliance of checking HbA1c in tertiary care hospital of a developing
world.
Methods: This was a retrospective observational study done from 1st February 2019 to 31st March 2019 in
the Department of Medicine and Surgery, The Aga Khan University Hospital, Karachi. All patients of age
18 years and above, admitted with a diagnosis of diabetes mellitus (DM) from 1st February 2019 to 31st
March 2019 were included. If HbA1c was less than 7% the patients were labelled as having controlled DM,
otherwise, uncontrolled DM. If HbA1c of patients with controlled DM was not checked in last six months
and if HbA1c of patients with uncontrolled DM was not checked in last three months then it was labelled
as non-compliance of checking HbA1c.
Results: Out of 1732 diabetic patients only 94 patients fulfilled inclusion criteria. Out of these 94 patients
43 (45.7%) were male. Mean HbA1c was 7.90% (1.4) and 69 (73.4%) patients had uncontrolled diabetes
mellitus. Overall, the compliance of checking HbA1c was 58.5%. In uncontrolled diabetes mellitus patients,
the compliance of checking HbA1c was 45% and in controlled diabetes mellitus patients the compliance
was 96%.
Conclusion: The compliance of checking HbA1c is inadequate in diabetic inpatients. The considerable
prevalence of diabetes and the benefits of timely interventions in diagnosed patients to prevent
complications suggest the need for a comprehensive awareness among the doctors for checking HbA1c.
KEYWORDS: HbA1c, Compliance, Developing country, Diabetes Mellitus.
doi: https://doi.org/10.12669/pjms.37.1.2814

How to cite this:

Aziz A, Ali SA. Compliance of checking HbA1c in a tertiary care hospital of Pakistan. Pak J Med Sci. 2021;37(1):142-145.
doi: https://doi.org/10.12669/pjms.37.1.2814
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

INTRODUCTION

Correspondence:
Dr. Abdul Aziz, FCPS (Medicine).
Fellow Endocrinology,
Diabetes and metabolism,
Department of Medicine,
Faculty Office Building,
The Aga Khan University Hospital,
Karachi, Pakistan.
Email: azizghilzai@gmail.com

*
*
*

Received for Publication:

June 15, 2020

Revision Received:

October 12, 2020

Revision Accepted:

October 18, 2020

Pak J Med Sci

January - February 2021

The prevalence of diabetes mellitus worldwide
was 171 million one and half decade ago, while the
prediction is 366 million patients by 2030.1Recent
estimates point to more than 640 million people
being affected by this disease by 2040.2 With clear
association with multiple comorbidities such as
cardiovascular disease,3,4 renal disease, infections,
Erase malignancy and functional impairment,
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diabetes places a huge financial burden on both
patients and health care systems. In 2012 the
American Diabetes Association (ADA) estimated
total economic cost of diabetes care in the United
States of about $245 billion.5
HbA1c value represents average blood
glucose over the past 2-3 months and accounts
for both pre-prandial and post-prandial blood
glucose levels. Regular HbA1c measurement
is recommended for all patients with diabetes
mellitus for the assessment of blood glucose
control.1,6,7 In diabetes care, HbA1c measurement
has been considered one of the most important
laboratory advances. A link between HbA1c
and diabetic complications has been confirmed
and the need for adequate blood glucose control
underscored.8 However, compliance to these
recommendations is very low.9 Measurement
of HbA1c was infrequent, occurring in only
18.4% of encounters where diabetes mellitus
was included as an admission diagnosis in a
study by Beatastrack et al.10 In general, patients
with controlled diabetes mellitus should have
at least biannual testing, while patients with
uncontrolled diabetes mellitus or unmet glycemic
targets should be tested every three months.6
On the robust literature search there is little data
available on the compliance of checking HbA1c in
developing countries. No data is available from
our country. By checking HbA1c timely, we can
modify the treatment and reduce complications of
diabetes mellitus. This provides strong rationale
to assess the magnitude of compliance of checking
HbA1c.

at or within three months for uncontrolled
diabetes mellitus and at or within six months
for controlled diabetes mellitus. Those patients
who were diagnosed as diabetes mellitus in the
latest admission and those whose data of HbA1c
is not available for last six months for controlled
diabetes mellitus and last three months for
uncontrolled diabetes mellitus were excluded.
Analysis was done by SPSS software package. To
determine the association between the variables P
<0.05 was supposed to be significant.

METHODS

Table-I: Characteristics and
compliance of checking HbA1c.

This was a retrospective observational study
from 1st February 2019 to 31st March 2019
conducted in the Department of Medicine and
Surgery, The Aga Khan University Hospital,
Karachi. The study was approved by Ethical
review committee of The Aga Khan University
Hospital (ERC No # 2019-1464-3628). Non
probability, consecutive sampling was adopted.
All patients of age 18 years and above, of both
genders, admitted in hospital with a diagnosis
of diabetes mellitus were included. All patients
who had HbA1c of less than 7% were said to have
controlled diabetes mellitus and those who had
HbA1c equal to or more than 7% were said to
have uncontrolled diabetes mellitus. A patient
was said to be compliant if HbA1c was checked
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RESULTS
A total of 1732 diabetic patients were admitted
from 1st February 2019 to 31stMarch 2019 in The
Aga Khan University Hospital Karachi, out of
which only 94 patients fulfilled our inclusion
criteria and were selected in our study. Out
of 94 diabetic patients 43 (45.7%) were male.
The mean age was 62.6 (14.1) years and mean
HbA1c was 7.90% (1.4). 69 (73.4%) patients had
uncontrolled diabetes mellitus while 25 (26.6%)
had controlled diabetes mellitus. Overall, the
compliance of checking HbA1c was 58.5%.
Within uncontrolled diabetes mellitus the
compliance of checking HbA1c was found in
31(45%) and within controlled diabetes mellitus
the compliance was found in 24 (96%) (P 0.00).
The baseline characteristics of study subjects
are given in Table-I and overall compliance in
controlled and uncontrolled diabetes mellitus is
given in Table-II.
The overall compliance in medicine was
49 (55.6%) and in surgery it was 6 (37.5%).

Value (SD)
Age (years)

62.6 (14.1)

Gender

Male

43 (45.7%)

Female

51 (54.3%)

HbA1c (%)

7.90 % (1.4)

Uncontrolled Diabetes Mellitus

69 (73.4%)

Controlled Diabetes Mellitus

25 (26.60%)

Compliant

55 (58.5%)

Non-compliant

39 (41.5%)

Vol. 37 No. 1

www.pjms.org.pk

143

Compliance of checking HbA1c

Table-II: Compliance of checking HbA1c
in controlled and uncontrolled diabetes mellitus.
P value
Overall (Total 94)

55 (58.5%)

In patients with controlled
diabetes mellitus (Total 25)

24 (96%)

In patients with
uncontrolled diabetes
mellitus (Total 69)

31 (45%)

0.00

In medicine subspecialties the compliance in the
descending order of frequency was neurology
eight (88.9%), pulmonology 8 (80%), cardiology
nine (69.2%), internal medicine 23 (60.5%),
gastroenterology 1 (33.3%) and nephrology
0(0%).
DISCUSSION
In our study the compliance rate of checking
HbA1c was inadequate. The compliance rate was
even poorer in those patients with uncontrolled
diabetes mellitus as compared to controlled
diabetes mellitus. The overall compliance rate
was 58.5% in our study which is similar to the
study by Graham Woodward et al, in which
the compliance of checking HbA1c was 58%.11
Our results are also similar to those of a smaller
Canadian study of physician charts, which found
that only 53% of patients with Type-2 diabetes
had HbA1c testing during one year.12 However,
these studies were carried out in developed
countries and in outpatient settings.
In a study conducted in primary healthcare in
Saudi Arabia by Siddqui MS et al the compliance
was 39%.13 In a study done in Bahrain HbA1c
was done twice a year in 20% of patients.14An
Ethiopian study found that none of study
subjects had HbA1c determination.15 A study by
Biatastrack et al showed that measurement of
HbA1c was infrequent, occurring in only 18.4% of
encounters where diabetes mellitus was included
as an admission diagnosis which is lower as
compared to our study.10
In our study the compliance was poorer
in uncontrolled diabetes mellitus (45%) as
compared to controlled diabetes mellitus (96%).
This finding is interesting as physicians and
surgeons should be more vigilant in assessing
status of diabetic patients with uncontrolled
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diabetes mellitus. However, in our study
physicians and surgeons were less vigilant for
patients with uncontrolled diabetes mellitus.
The reason for this is unknown. It may be merely
due to by chance.
Sub specialty-wise further analysis of our data
showed that compliance of checking HbA1c was
higher in the department of medicine as compared
to surgery. The compliance was highest in the
sub-specialties (e.g. neurology and cardiology)
where diabetes mellitus is an important risk
factor for the diseases like stroke and myocardial
infarction.
To the best of our knowledge there is no
inpatient study in South Asia on the compliance of
checking HbA1c which is an important predictor
of determining the control of diabetes mellitus.
Our study was carried out only in inpatient setting
and the resultant sample size was relatively small.
Large scale studies including outpatient setting
patients are required.
Limitation of the Study:
1. It was inpatient study and a small number of
patients were included.
2. The study subjects were not classified as type
1 diabetes mellitus, type 2 diabetes mellitus
and gestational diabetes mellitus.
CONCLUSIONS
The compliance of checking HbA1c is
inadequate in diabetic inpatients. The considerable
prevalence of diabetes and the benefits of timely
interventions, on the basis of HbA1c values, in
diagnosed patients to prevent complications
suggest the need for more awareness among the
doctors for checking HbA1c.
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